Commure

Commure has one wager: that the mountain of administrative work crushing American healthcare can be run by software, not just softened by it. Its pitch to hospitals is an AI-native platform that stretches across the whole care journey, from the ambient scribe listening in the exam room to the autonomous coder that turns that visit into a clean claim.

The company traces back to two threads that merged in 2023. Commure was incubated by General Catalyst in 2017 as shared healthcare infrastructure, and Athelas was built by Tanay Tandon and Deepika Bodapati starting in 2016. The combined company, led by Tandon as CEO and Bodapati as COO out of Mountain View, later folded in ambient-scribe maker Augmedix and now says it handles more than $25B in annual claims across 500-plus healthcare organizations. A $70M round in 2026 put a $7B valuation on that ambition.

Commure sells health systems a single AI platform that runs the parts of care nobody enjoys: documentation, coding, billing, and patient outreach. An ambient AI scribe writes the clinical note from the conversation, autonomous coding turns that note into billable charges, and a revenue-cycle engine pushes the claim through and fights the denials.

What makes it usable inside a hospital is the plumbing. Commure integrates with 60-plus EHRs including Epic and Cerner, so the AI sits inside the tools clinicians already open every day rather than asking them to learn a new one.

The company's own framing is blunt: complexity is killing healthcare. Providers drown in documentation, administrators chase endless denial queues, and revenue leaks out of every charge that gets documented but never billed. Commure aims those tools straight at that waste, from after-hours charting to timely-filing denials to the clipboard-era intake that it says costs health systems billions a year.

The recurring promise across its case studies is time given back. One clinician reports 350-plus hours a year saved on documentation, another cut charting time 41%, and a health system claims a 20% revenue lift after moving its revenue cycle onto Commure.

This is enterprise healthcare software, sold to the people who own the P&L and the clinical workflow: hospital finance leaders, revenue-cycle VPs, CMIOs, and the physicians and nurses who have to live with whatever they buy. The customer roster skews large, from academic medical centers to multi-site urgent care networks.

That focus is also the boundary. Commure is aimed at systems big enough to feel a $25B-claims-scale platform, not the solo practice down the street.

Commure's lineup maps to the stages of a patient encounter and the money that follows it. Ambient AI and Commure Pro handle documentation at the point of care, Engage and the AI call-center agents own patient access and outreach, and the RCM suite plus autonomous coding chase the revenue on the back end.

The portfolio also carries the DNA of its acquisitions, including Augmedix ambient documentation, Athelas remote patient monitoring, and Strongline staff-safety hardware, all pulled onto what the company calls a single data model.

Commure is enterprise B2B SaaS sold to health systems, and it does not publish prices. Deals are direct and consultative, often seven figures, with sales reps explicitly told to chase wins over $1M while planting seeds for land-and-expand growth inside big provider organizations.

That shape fits the product: once ambient scribing or RCM is embedded in an Epic workflow, adding the next module is an upsell, not a new sale.

Commure's edge, as it tells it, is breadth: rather than sell just an ambient scribe or just a coding tool, it runs documentation, coding, billing, and engagement on one AI-native data model. The counter-positioning is against best-of-breed point tools that leave hospitals stitching vendors together.

The strategy now is consolidation. Buying Augmedix and merging with Athelas were both moves to own more of the stack, and the company frames its direction as becoming the industry standard rather than one more upstart.

Commure leans hard on measured outcomes from named systems. Yale New Haven Health cut no-show and cancellation rates 54% with pre-appointment texting, an NYC health system reported a 20% revenue boost and a 53% drop in timely-filing denials on Commure RCM, and Mount Sinai saw a 20% increase in patients discharged directly home.

On the engagement side the company cites 80%-plus of patient inquiries resolved automatically and a 69 patient NPS. These are Commure's own case-study figures, but they are specific and attributed to real institutions.

Employees on Glassdoor land Commure around the middle, and the split is consistent. The praise: real ownership, smart colleagues, fast growth, and impact you can see because engineers work directly with clinicians. The company runs at startup speed and rewards people who want that.

The complaints are the flip side of the same coin. Reviewers describe things breaking often under pressure to ship features in a week, a very young executive bench, thin teams stretched across too much, and work-life balance that suffers when everything is urgent. It reads as a high-ownership, high-burn shop, not a place for a quiet nine-to-five.

Commure is a General Catalyst creation and General Catalyst is still its lead backer, most recently on a $70M round in 2026 that set a $7B post-money valuation with Sequoia Capital, Morgan Stanley, and Kirkland & Ellis joining. Company and press accounts put total funding around $750M, though third-party trackers count more once debt is included.

The capital arrives after a busy stretch of dealmaking: the 2023 Athelas merger that formed today's company at a roughly $6B valuation, and the $139M acquisition of Augmedix in 2024.

Commure wants to be the standard AI layer for how care is documented and financed, and it is spending acquisitions and capital to get there faster than it could organically. The pieces are in place: broad EHR reach, a stack that spans the workflow, and marquee systems willing to be named.

The open questions are the ones its own reviews raise. A $7B valuation and 500-plus enterprise customers demand reliability and maturity, and the fast-ship, thin-team culture that got Commure here is exactly what it will have to outgrow to keep them.

Commure runs itself like a company that never left day one: high ownership, lean staffing, and a stated aversion to management theater. Its own values put speed and output first, and its engineering pitch is that you ship daily and sit close enough to clinicians that the impact of your code is immediate.

The footprint is global. Mountain View is the hub, but large operations and engineering teams sit in India and Bangladesh, with roles also in Brazil and elsewhere. Sales runs remote-with-travel, and the office perks include the dog-friendly Mountain View HQ that shows up in its recruiting.

Across the roles that disclose pay, Commure's US engineering bands run widely, roughly $80,000 to $275,000 a year, reflecting everything from early-career to senior and staff levels. Operations and go-to-market roles cluster lower, with sales roles carrying commission on top of base.

Many India and Bangladesh roles are hired locally and post no US band. All figures here are base pay disclosed in job listings; equity is common at a company of this stage but is not spelled out in the postings.

Handling live clinical data means compliance is table stakes, and Commure's engineering roles reference HIPAA, SOC 2, HL7, and FHIR as the standards its integrations have to meet. The legal entity operates out of 1300 Terra Bella Ave, Suite 200, Mountain View, CA 94043.

One quirk worth noting for anyone dealing with the company: official communication comes from three domains, commure.com, getathelas.com, and augmedix.com, a direct artifact of the merger and acquisition that built it.

The recent headlines track a company buying and raising its way into scale. The 2026 $70M round at a $7B valuation drew coverage across the health-tech trade press, on top of earlier reporting on the Athelas merger and a $200M growth financing from General Catalyst.

Commure's own blog rounds out the picture with product news like end-to-end Cerner integration for its ambient AI, plus explainers on charge capture and clinical documentation.